Company intelligence / Profile preview

WonderLab

Ownership: Private
Development stage: Other

Overview

WonderLab provides an AI-powered mobile app delivering internet-based cognitive behavioral therapy (iCBT) for depression and other mental illnesses. The program is self-paced over eight weeks using multimedia interaction methods. The company is recognized as an outperformer in the digital therapeutics space for anxiety and depression. Clinical results are referenced as being supported by peer-reviewed research and randomized controlled trials within the broader market context but no specific trial data disclosed.

Therapeutic areas: Psychiatry
Modalities: Non-pharmacological therapy (digital cognitive behavioral therapy)Mobile app-based interventionArtificial intelligence-driven personalized therapy
Industry: Digital Health Medical Devices

Partnerships

No major pharmaceutical or biotech partnerships disclosed.

Beyond the preview

Go deeper on WonderLab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WonderLab.

Explore the full profile